JeanMarie Guenot is the CEO of Amphivena Therapeutics, a company that focuses on the development of therapies for hematologic malignancies. For over two decades, she has worked in the biotechnology and pharmaceutical industry. Over the years, Guenot has gained broad experience that has helped her to succeed in all her endeavors. She has worked for different companies, including private and public, pharmaceutical R&D, business development, corporate and commercial development, venture capital, and project & alliance management. JeanMarie is passionate about building or rebuilding companies. She has always been interested in therapeutic areas. Her most recent involvement was in ophthalmology where she assumed the role of key business and operating officer of SKS Ocular.
JeanMarie built and managed SKS Ocular, a startup ophthalmic company incubator. Its first portfolio of five companies, SKS Ocular 1, specialized in dry AMD and sustained release of delivery technologies for ocular drug and therapeutics for glaucoma, ocular inflammation and macular degeneration. Previously, JeanMarie Guenot worked for Hoffman-La Roche as a business advisor. She was stationed in Shanghai and Basel for two years. Formerly, she worked for PDL BioPharma as the vice president in charge of Corporate & Business Development. She was in charge of licensing, alliance management as well as mergers and acquisitions for the company’s R&D and commercial product portfolios. While here, she spearheaded the negotiation of the Biogen Idec-PDL 50:50. The deal involved three candidates of Phase 2 cancer and autoimmune disease drug. In 2005, she received the Innovative Bio-Partnering Award for her success in the Biogen Idec partnership. BioBusiness Network presented her with the award.
At PDL, Guenot made several accomplishments, including spinning of product rights from the PDL-Biogen Idec collaboration for Ophthotec, and playing a central role in the sale of the company’s commercial and manufacturing businesses. She was a member of PDL’s executive team and portfolio management committee. JeanMarie Guenot sat on the Joint Steering Committee for Biogen Idec-PDL Alliance. Her business career started at Atlas Venture where she gained immense knowledge on venture capital investments. In addition, she established life science companies. JeanMarie enrolled in the University of California and Wharton University of Pennsylvania where she earned her PhD and MBA respectively.
Jeanmarie Guenot and Maverick Therapeutics Announce Five-year Collaboration with Takeda